Basel, Basel, Switzerland
An accomplished biopharma executive with over 20 years of experience and a string of successes in launch and growth of orphan medicines and specialty therapeutics. Thanks to a solid scientific background and a deep business acumen, I understand the needs of all stakeholders, set a clear strategy and drive execution to success. I am a catalyst for growth with proven track record in building and leading high performing teams. I foster collaboration and inspire people to go the extra-mile, and have a keen ability to develop members of my team beyond their comfort zone, enabling them to reach extraordinary professional progress. I work through challenges with innovative thinking and an inclusive management approach that fosters trust and drives organizational empowerment.
Turning hope into disease-modifying therapies for people living with severe rare metabolic disorders
Reporting to the President, EMEA, responsible for leadership of strategic initiatives, including novel initiatives, real world data efforts, value added services, digital channels. Also responsible for managing commercial operations functions, including training, commercial excellence, project management and congress management, to drive regional commercial execution in alignment with global marketing across all franchises, products and indications.
Reporting to the President EMEA, responsible for: • building and executing the overall product, brand and indication strategy, and implementing a pan-European marketing plan in order to establish and drive the growth, across the whole region, of Celgene’s marketed and new products, as well as future disease indications. • providing key Brand Marketing expertise for the affiliates to provide adequate counselling to each country in line with its specific external & internal situation • leading the European Marketing Teams in: Strategic plan design, tactical implementation/action plans, portfolio management launch, and management pre- and post- marketing activities • providing commercial input into Market Access strategy, to ensure advanced input on health outcomes, clinical trial strategies, outcomes research and market access viability for each of the company’s assets • acting as the strategic channel between Corporate Development and Europe, representing European interests on a longer term perspective including Business Development • member of key EMEA and Global governance committees
General Manager of Celgene Italy affiliate. Completed the start up of the affiliate, bringing it from zero to 140 employees, > € 150 M revenues, making Celgene a leader in hematology in Italy
Establishment and start up of the Greek affiliate (25 employees), taking over business from the distributor and obtaining reimbursement for Genzyme products in the Greek market.
Leading the European Business Unit Rare Diseases. Responsible for the Marketing and Medical Affairs teams, providing leadership to the affiliates for the rare disease franchise (> € 350 M at the time).